Hypertrophic Cardiomyopathy

2011 ACCF/AHA Guidelines for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy


  • Compiled consensus on the most important diagnostic modalities and genetic testing tools for the treatment of hypertrophic cardiomyopathy (HCM)
  • Lists nomenclature distinguishing HCM from other genetic diseases
  • Suggests best practices from providers and institutions in improving quality of care to patients with HCM

    Read the Executive Summary in Circulation
    Circulation. 2011: published online before print November 8, 2011, doi: 10.1161/CIR.0b013e318223e230

    Read the full article in Circulation
    Circulation.  2011: published online before print November 8, 2011, doi: 10.1161/CIR.0b013e318223e2bd

Supporting Materials



Related Statements and Guidelines


Coming December 2011 to learn.heart.org

Diagnosis and Treatment of Hypertrophic Cardiomyopathy (HCM)

The American Heart Association is launching a new educational series entitled, Guidelines into Practice, designed to enhance participants' awareness, knowledge and applicability of newly released guidelines as applied to their interactions with cardiovascular disease and stroke patients.  The format includes an online CME/CE program with enduring materials that will be developed based upon highlights of the Hypertrophic Cardiomyopathy guidelines, case studies to illustrate patient applicability and resource materials.  Continuing education credit will be available for physicians and nurses.





Posted by Stacy AHA Science on Nov 8, 2011 1:28 PM America/Chicago